Delivery Order SPE2DB22D1106-SPE2DB25FFCG1
- Not listed
- The Defense Logistics Agency awarded a $16,438.36 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Norepinephrine 8 mg/250 ml in D5W 250 ml formulation, with an ultimate completion date of September 17, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is serving as the prime contractor through its...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,323.74 on August 8, 2025, for the supply of Norepinephrine 8 mg/250 ml in D5W 250 ml units. This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a non-set-aside competitive award from the Defense Logistics Agency's Medical Supply Chain, with performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. Norepinephrine is a critical vasopressor medication used...
- The Defense Logistics Agency awarded a $7,210.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Norepinephrine 4 mg/250 ml in dextrose 5% water solution (250 ml units). The contract was competitively awarded without set-aside designation and is scheduled for completion by September 22, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Norepinephrine 8 mg/250 ml in D5W (dextrose 5% in water) solution in 250 ml units. This contract, valued at $1,488.34, is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025. The award was competitively procured with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Norepinephrine 8 mg/250 mL in D5W solution with a ceiling value of $1,549.16. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,943.88 on July 29, 2025, for the supply of Norepinephrine 4 mg/4 ml vials. This firm fixed-price contract, which carries an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Norepinephrine 4 mg/4 ml vials with a ceiling value of $1,107.83. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Norepinephrine 4 mg/250 mL in 0.9% sodium chloride solution, a critical vasoactive medication used in acute care and emergency medical settings. This firm fixed-price delivery order, valued at $2,165.76, represents a child contract under AmerisourceBergen's larger $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs...
- The Defense Logistics Agency Troop Support Medical awarded a $626 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562195962 norepinephrine 8 mg/250 ml-D5W 250ml. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 15 through September 18, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,135.00 by the Defense Logistics Agency's Medical Supply Chain for the provision of Norepinephrine 4 mg/4 mL vials. The contract, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed price delivery under a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFCG1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,900.40 to AmerisourceBergen Drug Corp for the supply of Norepinephrine 8 mg/250 mL in D5W solution (250 mL units). This firm fixed price delivery order, issued on August 8, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 11, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999.999 billion through December 2026. The underlying IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. Norepinephrine is a critical vasopressor medication used in military and veteran healthcare settings for treating hypotension and shock in acute medical situations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/8/25 |